Lv et al (52) discovered that EFTUD2 protein levels are abnormally increased in colorectal cancer and reduced EFTUD2 levels leads to a marked decrease in both the number and size of colorectal tumors, but an increase in low-grade dysplasia. The gene discussed is EFTUD2; the disease is colorectal neoplasm.